Addex Therapeutics
Discovers and develops small molecule oral drugs to treat a range of medical conditions. Learn more
Launch date
Employees
Market cap
€7.6m
Enterprise valuation
€6m (Public information from Sep 2024)
Share price
CHF0.0704 ADXN.SW
Company register number CH-660.0.659.007-3
Geneva Canton of Geneva (HQ)
Authorizing premium user...